
Crizalk (Crizotinib)
Categories: Anti Cancer, Life Saving Drugs, Lung Cancer
Medicine Overview
Crizalk, containing Crizotinib, is an advanced targeted therapy for non-small cell lung cancer (NSCLC) patients with ALK-positive mutations. It inhibits cancer cell growth and helps slow tumor progression, improving patient outcomes. Designed for precision treatment, it enhances quality of life while minimizing side effects compared to conventional chemotherapy. Crizalk is suitable for adults diagnosed with ALK-positive NSCLC seeking effective oral therapy. Its benefits include improved tumor response, oral convenience, and reliable daily dosing.
Detailed Specifications
SKU | Crizalk (Crizotinib) - 250 Mg |
Active Ingredient | Afatinib Dimaleate |
Strength | 20mg |
Manufacturer | Boehringer Ingelheim India Pvt.Ltd |
Packaging | 7 tablets in 1 strip |
Fast & Reliable Delivery
Expect your order to arrive within 8-15 business days.
Secure Payments
Enjoy peace of mind with our 100% secure payment gateway.
24/7 Customer Support
We're here to help you around the clock.
Important Disclaimer:
The information provided on BuyGenericDrug.com is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. For urgent queries or medical advice, please consult a healthcare professional. For general inquiries about our services, feel free to contact us at: buygenericdrugs3@gmail.com.